Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 50 (NPM1P50) is a processed pseudogene derived from the parental NPM1 gene, which encodes the nucleophosmin (NPM, also known as B23, numatrin) protein, a multifunctional nucleolar phosphoprotein that plays key roles in ribosome biogenesis, genomic stability, and regulation of the cell cycle. Unlike the functional NPM1 gene, NPM1P50 is noncoding and typically does not produce a functional protein due to mutations or lack of necessary regulatory sequences. Processed pseudogenes are formed via retrotransposition and integrate randomly in the genome, lacking introns and often being transcriptionally silent. While some pseudogenes can be transcribed and play regulatory roles—such as acting as competing endogenous RNAs or miRNA sponges—no evidence currently links NPM1P50 to such functions.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 50 (NPM1P50).